285 related articles for article (PubMed ID: 37178319)
21. Antimicrobial and synergistic activity of thiazoline derivatives in combination with conventional antibiotics against multidrug resistant Staphylococcus aureus isolated from abscess drainage samples.
Khan MA; Ali S; Shamim S; Ahmed N; Hussain M; Farooq S; Khan S
Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2331-2339. PubMed ID: 33832908
[TBL] [Abstract][Full Text] [Related]
22. Bacteriophage Therapy for
Plumet L; Ahmad-Mansour N; Dunyach-Remy C; Kissa K; Sotto A; Lavigne JP; Costechareyre D; Molle V
Front Cell Infect Microbiol; 2022; 12():907314. PubMed ID: 35782148
[No Abstract] [Full Text] [Related]
23. Is there any rationale for treatment of Staphylococcus aureus infections with antimicrobials that are determined to be ineffective in vitro?
Uekötter A; Peters G; Becker K
Clin Microbiol Infect; 2011 Aug; 17(8):1142-7. PubMed ID: 21672081
[TBL] [Abstract][Full Text] [Related]
24. Staphylococcus aureus adhesion to the host.
Berry KA; Verhoef MTA; Leonard AC; Cox G
Ann N Y Acad Sci; 2022 Sep; 1515(1):75-96. PubMed ID: 35705378
[TBL] [Abstract][Full Text] [Related]
25. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2019.
Coombs GW; Daley DA; Mowlaboccus S; Pang S;
Commun Dis Intell (2018); 2020 Sep; 44():. PubMed ID: 32988337
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic options and emerging alternatives for multidrug resistant staphylococcal infections.
Magana M; Ioannidis A; Magiorkinis E; Ursu O; Bologa CG; Chatzipanagiotou S; Hamblin MR; Tegos GP
Curr Pharm Des; 2015; 21(16):2058-72. PubMed ID: 25760340
[TBL] [Abstract][Full Text] [Related]
27. The importance of the development of antibiotic resistance in Staphylococcus aureus.
Schito GC
Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():3-8. PubMed ID: 16445718
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions.
Bishop EJ; Howden BP
Expert Opin Emerg Drugs; 2007 Mar; 12(1):1-22. PubMed ID: 17355211
[TBL] [Abstract][Full Text] [Related]
29. Cervimycin-Resistant Staphylococcus aureus Strains Display Vancomycin-Intermediate Resistant Phenotypes.
Dietrich A; Steffens U; Gajdiss M; Boschert AL; Dröge JK; Szekat C; Sass P; Malik IT; Bornikoel J; Reinke L; Maček B; Franz-Wachtel M; Nieselt K; Harbig T; Scherlach K; Brötz-Oesterhelt H; Hertweck C; Sahl HG; Bierbaum G
Microbiol Spectr; 2022 Oct; 10(5):e0256722. PubMed ID: 36173303
[TBL] [Abstract][Full Text] [Related]
30. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus.
Rehm SJ; Tice A
Clin Infect Dis; 2010 Sep; 51 Suppl 2():S176-82. PubMed ID: 20731575
[TBL] [Abstract][Full Text] [Related]
31. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
[TBL] [Abstract][Full Text] [Related]
32. Alternative therapies in Staphylococcus aureus diseases.
Kurlenda J; Grinholc M
Acta Biochim Pol; 2012; 59(2):171-84. PubMed ID: 22577619
[TBL] [Abstract][Full Text] [Related]
33. Multidrug and vancomycin resistance among clinical isolates of
Olufunmiso O; Tolulope I; Roger C
Afr Health Sci; 2017 Sep; 17(3):797-807. PubMed ID: 29085408
[TBL] [Abstract][Full Text] [Related]
34. The changing face of Staphylococcus aureus: a continuing surgical challenge.
Fry DE; Barie PS
Surg Infect (Larchmt); 2011 Jun; 12(3):191-203. PubMed ID: 21812657
[TBL] [Abstract][Full Text] [Related]
35. Effects of the antimicrobial peptide L12 against multidrug‑resistant Staphylococcus aureus.
Xiong F; Dai X; Li YX; Wei R; An L; Wang Y; Chen Z
Mol Med Rep; 2019 Apr; 19(4):3337-3344. PubMed ID: 30816474
[TBL] [Abstract][Full Text] [Related]
36. Characterization of antimicrobial-resistant Staphylococcus aureus from retail foods in Beijing, China.
Li H; Tang T; Stegger M; Dalsgaard A; Liu T; Leisner JJ
Food Microbiol; 2021 Feb; 93():103603. PubMed ID: 32912578
[TBL] [Abstract][Full Text] [Related]
37. The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes.
Cameron DR; Howden BP; Peleg AY
Clin Infect Dis; 2011 Sep; 53(6):576-82. PubMed ID: 21865195
[TBL] [Abstract][Full Text] [Related]
38. In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus.
Narayanaswamy VP; Giatpaiboon SA; Uhrig J; Orwin P; Wiesmann W; Baker SM; Townsend SM
PLoS One; 2018; 13(1):e0191522. PubMed ID: 29342216
[TBL] [Abstract][Full Text] [Related]
39. Staphylococcus aureus and its Bearing on Ophthalmic Disease.
Sadaka A; Durand ML; Sisk R; Gilmore MS
Ocul Immunol Inflamm; 2017 Feb; 25(1):111-121. PubMed ID: 26679534
[TBL] [Abstract][Full Text] [Related]
40. Into the storm: Chasing the opportunistic pathogen Staphylococcus aureus from skin colonisation to life-threatening infections.
O'Gara JP
Environ Microbiol; 2017 Oct; 19(10):3823-3833. PubMed ID: 28631399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
